The effects of hormones on urinary incontinence in postmenopausal women

References

• Losif C S, Batra S, Ek A, Astedt B. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 1981; 141: 817–820
   PubMed Web of Science ®Google Scholar
• Thomas T M, Plymat K R, Blannin J, Meade T W. Prevalence of urinary incontinence. BMJ 1980; 281: 1243–1245
   PubMed Web of Science ®Google Scholar
• Jolleys J V. Reported prevalence of urinary incontinence in women in a general practice. BMJ 1988; 296: 1300–1302
   PubMed Web of Science ®Google Scholar
• Kondo A, Kato K, Saito M, Otani T. Prevalence of incontinence in females in comparison with stress and urge incontinence. Neurourol Urodynam 1990; 9: 330–331
   Google Scholar
• Nitti V W. The prevalence of urinary incontinence. Rev Urol 2001; 3(Suppl 1)S2–S6
   PubMedGoogle Scholar
• Losif C S, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984; 63: 257–260
   PubMed Web of Science ®Google Scholar
• Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003; 2: CD001405
   PubMedGoogle Scholar
• Gebhardt J, Richard D, Barrett T. Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol 2001; 185: 1325–1330
   PubMed Web of Science ®Google Scholar
• Bai S W, Jung Y W, Kwon H S, et al. The role of estrogen receptor, progesterone receptor and p53 in development of stress urinary incontinence. Yonsei Med J 2004; 45: 885–890
   PubMed Web of Science ®Google Scholar
• Xie Z, Shi H, Zhou C, Dong M, Hong L, Jin H. Alterations of estrogen receptor-α and -β in the anterior vaginal wall of women with urinary incontinence. Eur J Obstet Gynecol Reprod Biol 2007; 134: 254–258
   PubMed Web of Science ®Google Scholar
• Fu X, Rezapour, Wu X, Li L, Sjogren C, Ulmsten U. Expression of estrogen receptor-α and -β in anterior vaginal walls of genuine stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14: 276–281, discussion 281
   PubMed Web of Science ®Google Scholar
• Pang X, Cotreau-Bibbo M M, Sant G R, et al. Bladder mast cell expression of high affinity oestrogen receptors in patients with interstital cystitis. Br J Urol 1995; 75: 154–161
   PubMedGoogle Scholar
• Brincat M P, Baron Y M, Galea R. Estrogens and the skin. Climacteric 2005; 8: 110–123
   PubMed Web of Science ®Google Scholar
• Robinson D, Cardozo L. The role of estrogens in female lower urinary tract dysfunction. Urology 2003; 62: 45–51
   PubMed Web of Science ®Google Scholar
• Waetjen L E, Dwyer P L. Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients. Int Urogynecol J 2006; 17: 541–545
   PubMed Web of Science ®Google Scholar
• Keane D P, Sims T J, Abrams P, Bailey A J. Analysis of collagen status in premenopausal nulliparous women with genuine stress in continence. Br J Obstet Gynaecol 1997; 104: 994–998
   PubMedGoogle Scholar
• Falconer C, Ekman-Ordeburg G, Blomgren B, et al. Paraurethral connective tissue in stress-incontinent women after menopause. Acta Obstet Gynecol Scand 1998; 77: 95–100
   PubMed Web of Science ®Google Scholar
• Sartori M G, Girão M J, de Jesus Sim[otilde]es M, Sartori J P, Baracat E C, Rodrigues de Lima G. Quantitative evaluation of collagen and muscle fibers in the lower urinary tract of castrated and under-hormone replacement female rats. Clin Exp Obstet Gynecol 2001; 28: 92–96
   PubMedGoogle Scholar
• Fleischmann N, Christ G, Sclafani T, Melman A. The effect of ovariectomy and long-term estrogen replacement on bladder structure and function in the rat. J Urol 2002; 168: 1265–1268
   PubMed Web of Science ®Google Scholar
• Aikawa K, Sugino T, Matsumoto S, Chichester P, Whitbeck C, Levin R M. The effect of ovariectomy and estradiol on rabbit bladder smooth muscle contraction and morphology. J Urol 2003; 170: 634–637
   PubMed Web of Science ®Google Scholar
• Endo R M, Girao M J, Sartori M G, Simoes M J, Baracat E C, Rodrigues de Lima G. Effect of estrogen–progestogen hormonal replacement therapy on periurethral and bladder vessels. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11: 120–123
   PubMed Web of Science ®Google Scholar
• Rud T, Andersson K E, Asmussen M, Hunting A, Ulmsten U. Factors maintaining the intraurethral pressure in women. Invest Urol 1980; 17: 343–347
   PubMedGoogle Scholar
• Zoubina E V, Mize A L, Alper R H, Smith P G. Acute and chronic estrogen supplementation decreases uterine sympathetic innervations in ovariectomized adult virgin rats. Histol Histopathol 2001; 16: 989–996
   PubMed Web of Science ®Google Scholar
• Shenforild O Z, Blackmore P F, Morgan C W. Rapid effects of estriol and progesterone on tone and spontaneous rhythmic contractions of the rabbit bladder. Neurourol Urodyn 1998; 17: 408–409
   Google Scholar
• Blakeman P J, Hilton P. Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int 2000; 86: 32–38
   PubMed Web of Science ®Google Scholar
• Hextall A, Bidmead J, Cardozo L, Hooper R. The impact of the menstrual cycle on urinary symptoms and the results of urodynamic investigation. Br J Obstet Gynaecol 2001; 108: 1193–1196
   Google Scholar
• Miodrag A, Castleden C M, Vallance T R. Sex hormones and the female urinary tract. Drugs 1988; 36: 491–504
   PubMed Web of Science ®Google Scholar
• Kristiansson P, Samuelsson E, von Schoultz B, Svärdsudd K. Reproductive hormones and stress urinary incontinence in pregnancy. Acta Obstet Gynecol Scand 2001; 80: 1125–1130
   PubMed Web of Science ®Google Scholar
• Foidart J M. Added benefits of drospirenone for compliance. Climacteric 2005; 8(Suppl 3)28–34
   PubMedGoogle Scholar
• Fantl J A, Cardozo L, McClish D K. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994; 83: 12–18
   PubMed Web of Science ®Google Scholar
• Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998; 92: 722–727
   PubMed Web of Science ®Google Scholar
• Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: Third report of the Hormones and Urogenital Therapy Committee. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12: 15–20
   PubMed Web of Science ®Google Scholar
• Cardozo L, Lose G, McClish D, Versi E. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand 2004; 83: 892–897
   PubMed Web of Science ®Google Scholar
• Grodstein F, Lifford K, Resnick N M, Curhan G C. Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol 2004; 103: 254–260
   PubMed Web of Science ®Google Scholar
• Steinauer J E, Waetjen L E, Vittinghoff E, et al. Postmenopausal hormone therapy: does it cause incontinence. Obstet Gynecol 2005; 106: 940–945
   PubMed Web of Science ®Google Scholar
• Hendrix S L, Cochrane B B, Nygaard I E, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005; 293: 935–948
   PubMed Web of Science ®Google Scholar
• Shamliyan T A, Kane R L, Wyman J, Wilt T J. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008; 148: 459–473
   PubMed Web of Science ®Google Scholar
• Holtedahl K, Verelst M, Schiefloe A. A population based, randomized, controlled trial of conservative treatment for urinary incontinence in women. Acta Obstet Gynecol Scand 1998; 77: 671–677
   PubMed Web of Science ®Google Scholar
• Rufford J, Hextall A, Cardozo L, Khullar V. A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14: 78–83
   PubMed Web of Science ®Google Scholar
• Waetjen L E, Brown J S, Vittinghoff E, et al. The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women. Obstet Gynecol 2005; 106: 946–952
   PubMed Web of Science ®Google Scholar
• Akhila V, Pratapkumar. A comparison of transdermal and oral HRT for menopausal symptom control. Int J Fertil Womens Med 2006; 51: 64–69
   PubMed Web of Science ®Google Scholar
• Mikkelsen A L, Felding C, Clausen H V. Clinical effects of preoperative oestradiol treatment before vaginal repair operation. A double-blind, randomized trial. Gynecol Obstet Invest 1995; 40: 125–128
   PubMed Web of Science ®Google Scholar
• Jackson S, James M, Abrams P. The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. Br J Obstet Gynaecol 2002; 109: 339–344
   Google Scholar
• Edwall L, Carlström K, Jonasson A F. Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodyn 2007; 26: 410–415
   PubMed Web of Science ®Google Scholar
• Henalla S M, Millar D R, Wallace K J. Surgical versus conservative management for post-menopausal genuine stress incontinence of urine. Neurourol Urodyn 1990; 9: 436–437
   Google Scholar
• Cardozo L D, Wise B G, Benness C J. Vaginal oestradiol for the treatment of urinary tract symptoms in postmenopausal women – a double-blind placebo-controlled study. J Obstet Gynaecol 2001; 21: 383–385
   PubMedGoogle Scholar
• Assassa R P, Jagger C, Williams K, McGrother C, Mayne C. Randomised double-blind placebo controlled trial of topical oestrogen in the treatment of female bladder symptoms. Int Urogynecol J 2003; 14(Suppl 1)S43
   Google Scholar
• Enzelsberger H, Kurz C, Schatten C, Huber J. The effectiveness of intravaginal estriol tablet administration in women with urge incontinence. Geburtshilfe Frauenheilkd 1991; 51: 834–838
   PubMed Web of Science ®Google Scholar
• Long C Y, Liu C M, Hsu S C, Chen Y H, Wu C H, Tsai E M. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril 2006; 85: 155–160
   PubMed Web of Science ®Google Scholar
• Serati M, Salvatore S, Uccella S, Cardozo L, Bolis P. Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?. Eur Urol Jun 20, 2008, [Epub ahead of print]
   Web of Science ®Google Scholar
• Raz R, Stamm W E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753–756
   PubMed Web of Science ®Google Scholar
• Moore E E, Jackson S L, Boyko E J, Scholes D, Fihn S D. Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol 2008; 111: 317–323
   PubMed Web of Science ®Google Scholar